14-day Premium Trial Subscription Sign Up For FreeGet Free

Amedisys Inc Stock Forecast NASDAQ:AMED

Price Target and Analyst Ratings

Most Recent Rating

On September 09, 2021 "Cowen" gave "" rating for AMED. The price target was changed from $183.01 to 1.1%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-09 Initiated by Cowen $183.01 $183.01→1.1%
2021-08-11 $330.00 - $250.00 Target Lowered by Credit Suisse Group $185.15 $193.80→3.2%
2021-08-10 $325.00 - $235.00 Target Lowered by Benchmark $193.80 $200.15+4.6%
2021-08-09 $325.00 - $250.00 Target Lowered by Raymond James $200.15 $200.15+4.6%
2021-08-06 $325.00 - $265.00 Target Lowered by Oppenheimer $191.34 $200.13→21.9%
2021-08-06 $310.00 - $237.00 Target Lowered by Stephens $191.34 $200.13→21.9%
2021-08-05 $220.00 Downgraded by Bank of America $200.13 $256.27→1.1%
2021-04-30 Outperform Target Raised by Royal Bank of Canada $269.85 $335.00 → $350.00
2021-03-01 Buy Target Raised by Benchmark $255.15 $275.00 → $325.00
2021-02-23 Positive - Buy Target Raised by Benchmark $280.27 $275.00 → $325.00
2021-02-08 Buy Target Raised by Deutsche Bank Aktiengesellschaft $305.02 $275.00 → $340.00
2021-01-05 Target Raised by Truist $289.85 $280.00 → $325.00
2020-11-03 Overweight Target Raised by Barclays $260.23 $290.00 → $298.00
2020-10-30 Buy Target Raised by Deutsche Bank Aktiengesellschaft $259.00 $260.00 → $275.00
2020-10-30 Outperform Target Raised by Credit Suisse Group $259.00 $246.00 → $280.00
2020-09-21 Outperform Target Raised by Oppenheimer $240.24 $250.00 → $260.00
2020-09-10 Equal Weight Reiterated by Stephens $228.47 $235.00 → $245.00
2020-09-02 Market Perform Target Raised by BMO Capital Markets $248.10 $250.00 → $270.00
2020-08-20 Overweight Initiated by Barclays $238.67 $290.00 → $290.00
2020-07-30 Outperform Target Raised by Royal Bank of Canada $234.39 $218.00 → $260.00
2020-07-30 Buy Target Raised by Benchmark $234.39 $210.00 → $250.00
2020-07-30 Buy Target Raised by Deutsche Bank $234.39 $220.00 → $260.00
2020-07-30 Outperform Target Raised by Raymond James $234.39 $210.00 → $255.00
2020-07-29 Buy Target Raised by Jefferies Financial Group $228.82 $225.00 → $250.00
2020-06-18 Hold - Buy Upgraded by Benchmark $189.58 $210.00
2020-05-21 Buy Target Raised by SunTrust Banks $191.80 $225.00 → $240.00
2020-05-11 Neutral Target Lowered by UBS Group $178.03 $208.00 → $190.00
2020-05-11 Outperform Target Lowered by Raymond James $178.03 $225.00 → $210.00
2020-05-10 Buy Reiterated by Royal Bank of Canada $180.04 $218.00
2020-05-07 Buy - Hold Downgraded by Benchmark $171.78
2020-04-27 Buy Reiterated by Oppenheimer $191.99 $215.00

AMED Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -35.62% during the next 3 months and, with a 90% probability hold a price between $103.92 and $130.21 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $159.65 $180.06 $200.47
2021-09-21 $157.87 $178.28 $198.70
2021-09-22 $156.09 $176.51 $196.92
2021-09-23 $154.32 $174.73 $195.15
2021-09-24 $152.54 $172.96 $193.37
2021-09-27 $150.77 $171.18 $191.59
2021-09-28 $148.99 $169.40 $189.82
2021-09-29 $147.21 $167.63 $188.04
2021-09-30 $145.44 $165.85 $186.27
2021-10-01 $143.66 $164.08 $184.49
2021-10-04 $141.89 $162.30 $182.71
2021-10-05 $140.11 $160.52 $180.94
2021-10-06 $138.33 $158.75 $179.16
2021-10-07 $136.56 $156.97 $177.39
2021-10-08 $134.78 $155.20 $175.61
2021-10-11 $133.01 $153.42 $173.84
2021-10-12 $131.23 $151.64 $172.06
2021-10-13 $129.45 $149.87 $170.28
2021-10-14 $127.68 $148.09 $168.51
2021-10-15 $125.90 $146.32 $166.73
2021-10-18 $124.13 $144.54 $164.96
2021-10-19 $122.35 $142.77 $163.18
2021-10-20 $120.58 $140.99 $161.40
2021-10-21 $118.80 $139.21 $159.63
2021-10-22 $117.02 $137.44 $157.85
2021-10-25 $115.25 $135.66 $156.08
2021-10-26 $113.47 $133.89 $154.30
2021-10-27 $111.70 $132.11 $152.52
2021-10-28 $109.92 $130.33 $150.75
2021-10-29 $108.14 $128.56 $148.97

About Amedisys Inc

Amedisys Amedisys, Inc., together with its subsidiaries, provides home health, and hospice and personal care services. The company’ Home Health segment offers a range of services in the homes of individuals who may be recovering from illness, injury, or surgery through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks. Its Hospice segment offers care that is ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT